Medtronic plc (VIE:MDT)
Austria · Delayed Price · Currency is EUR | Market Cap | 91.38B -7.7% |
| Revenue (ttm) | 30.18B +6.9% |
| Net Income | 3.92B +8.3% |
| EPS | 3.04 +9.5% |
| Shares Out | n/a |
| PE Ratio | 23.29 |
| Forward PE | 14.24 |
| Dividend | 2.43 (3.44%) |
| Ex-Dividend Date | Mar 27, 2026 |
| Volume | n/a |
| Average Volume | 0 |
| Open | 70.98 |
| Previous Close | 70.78 |
| Day's Range | 70.72 - 70.98 |
| 52-Week Range | 70.20 - 91.24 |
| Beta | n/a |
| RSI | 26.62 |
| Earnings Date | Jun 3, 2026 |
About Medtronic
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc... [Read more]
Financial Performance
In fiscal year 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.
Financial numbers in USD Financial StatementsNews
Medtronic says cyberattack on IT network has not disrupted operations
Medical device maker Medtronic said on Monday a cyberattack on its computer systems last week did not affect its products or ability to meet patient needs, and is not expected to materially impact i...
Medtronic announces key Affera™ clinical study milestones for Sphere-9™ and Sphere-360™ catheters as global adoption continues
HRS late-breaking data: Interim results highlight six-month outcomes for patients treated with the Sphere-9 catheter for sustained monomorphic ventricular tachycardia (VT) Breakthrough device designat...
Medtronic completes acquisition of CathWorks, expanding its leadership in transforming care for patients with cardiovascular disease
CathWorks FFRangio® System employs drug-free, wire-free technology for comprehensive physiological assessment GALWAY, Ireland, April 20, 2026 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader ...
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Medtronic to announce financial results for its fourth quarter and full fiscal year 2026
GALWAY, Ireland, April 13, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Wednesday, June 3, 2026, f...
GE HealthCare announces digital integration between bkActiv™ intraoperative ultrasound system and Medtronic Stealth AXiS™ surgical navigation system
CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced a digital integration between the GE HealthCare bkActiv™ intraoperative ultrasound (iUS) system and the Medtronic Stealth AXiS™ surgical navigat...
Medtronic gets US FDA nod to use surgical system in cranial, ENT surgeries
Medtronic said on Friday the U.S. Food and Drug Administration has cleared its surgical system for use in cranial and ear, nose and throat procedures, expanding the platform beyond the sp...
Medtronic Receives FDA Clearance for Stealth AXiS™ Surgical System for Cranial and ENT Procedures
GALWAY, Ireland, March 27, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) clearance of the Stealth AXiS™ ...
Medtronic OmniaSecure™ defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing
Built for high reliability, world's only lumenless defibrillation lead approved for placement in the left bundle branch area GALWAY, Ireland, March 23, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), ...
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Medtronic Transcript: Leerink Global Healthcare Conference 2026
Accelerated product launches, strategic M&A, and portfolio actions have driven strong momentum, with high single-digit EPS growth targeted for next year. CAS, renal denervation, and Altaviva are key growth drivers, while the MiniMed separation and selective commercialization of Hugo and Stealth Access platforms support long-term value creation.
Medtronic Transcript: Barclays 28th Annual Global Healthcare Conference
Middle East exposure and oil price impacts are minimal, with logistics well managed and cost effects delayed by inventory cycles. The MiniMed separation is on track, supporting focused growth and higher margins, while CAS, Hugo, and Ardian franchises are set to drive accelerating growth and EPS leverage into 2027.
Medtronic to buy Scientia Vascular in $550 million deal
Medical device maker Medtronic said on Tuesday it has agreed to buy U.S.-based Scientia Vascular in a deal valued at $550 million, aiming to expand its line-up of products used in stroke care.
Medtronic to acquire Scientia Vascular, marrying access and therapeutic portfolios for neurovascular care
Deal complements Medtronic's Neurovascular portfolio, delivering simplicity and access when 'time is brain' GALWAY, Ireland, March 10, 2026 /PRNewswire/ -- Medtronic today announced its entry into a d...
Medtronic's diabetes unit MiniMed valued at $5.3 billion as shares fall in Nasdaq debut
Shares of MiniMed , the diabetes business of medical device maker Medtronic , opened 4.8% below their offer price in their Nasdaq debut on Friday, valuing it at $5.3 billion.
MiniMed to begin trading on Nasdaq Global Select Market
GALWAY, Ireland, March 6, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced that MiniMed Group, Inc. (Nasdaq: MMED) will begin trading today on the Na...
Medtronic's diabetes unit MiniMed raises $560 million in US IPO
MiniMed, the diabetes business of medical device maker Medtronic , said on Thursday it has raised $560 million in its U.S. initial public offering.
MiniMed announces pricing of initial public offering
GALWAY, Ireland and NORTHRIDGE, Calif., March 5, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed), a subsidiary of Medtronic plc (Medtronic) (NYSE: MDT), today announced the pricing of its initial p...
Medtronic announces cash dividend for fourth quarter of fiscal year 2026
GALWAY, Ireland, March 5, 2026 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE:MDT) on Thursday, March 5, 2026, approved the company's cash dividend for the fourth quarter of fiscal year...
3 Dividend Stocks for March 2026
These dividend-growth stocks are attractive today.
Medtronic CFO Thierry Piéton to speak at upcoming investor conferences
GALWAY, Ireland, March 3, 2026 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that Thierry Piéton, Medtronic executive vice president and chief fin...
Medtronic begins EMEA commercial launch of MiniMed Go Smart MDI system with Simplera sensor
Real-time actionable insights on one mobile app for people who manage their diabetes using multiple daily injections GALWAY, Ireland, Feb. 25, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global lead...
MiniMed announces launch of IPO roadshow
GALWAY, Ireland, Feb. 24, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed), a subsidiary of Medtronic plc (Medtronic) (NYSE: MDT), today announced that it has launched a roadshow for the initial pub...
Medtronic's MiniMed aims to raise $784 million in US IPO
Medtronic's diabetes business MiniMed Group said on Tuesday it was aiming to raise as much as $784 million in its initial public offering in the United States.
Medtronic Analysts Cut Their Forecasts After Q3 Earnings
Medtronic PLC (NYSE: MDT) posted better-than-expected earnings for the third quarter on Tuesday.